Detalhe da pesquisa
1.
The effect of British Columbia's Pharmacare coverage expansion for opioid agonist treatment.
Health Econ
; 30(5): 1222-1238, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711186
2.
Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada.
Addiction
; 117(5): 1353-1362, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34729848
3.
The effect of a methadone reformulation on opioid agonist treatment outcomes: A population-based study in British Columbia, Canada, 2013-14.
J Subst Abuse Treat
; 138: 108714, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101357
4.
Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol.
BMJ Open
; 11(6): e048353, 2021 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108170
5.
The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada.
Addiction
; 115(8): 1482-1493, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31899565
6.
Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada.
BMJ Open
; 10(9): e036102, 2020 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32912944